AllDocs -> cancers

Cancer Issue Addressing The Threat Fighting Breast Cancer Examining The Family Tree Genetics And Cancer Prevention Survival Rates Improving Rare Children’s Bone Tumors Tots Through Teens The Role Of Pediatric Oncology Ancient Chinese Medicine Acupuncture & Cancer Patients Kicking The Habit Smokers Reduce Cancer Risk Visit Our Website At: www. med.sc.edu/specialtyclinics 2 3 4 6 9 11 See Colon Cancer Research on Page 8. March 2004 Research Explores Colon Cancer Prevention "We potentially have a weapon here, but the side effects make it just too dangerous to use right now." Dr. Michael Wargovich It’s a disease that people have an aversion to discussing. There’s an even greater aversion to its screen- ing exam. Not the case ...

Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia Baozhong Xin 1,2 , Petra Platzer 1,2,5 , Stephen P Fink 1,2,5 , Lisa Reese 1,2 , Arman Nosrati 1,2 , James KV Willson 1,2 , Keith Wilson 3,5 and Sanford Markowitz* ,1,2,4,5 1 Department of Medicine and Ireland Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA; 2 University Hospitals of Cleveland, Cleveland, OH 44106, USA; 3 Protein Design Labs, Fremont, CA 94555, USA; 4 Howard Hughes Medical Institute, Cleveland, OH 44106, USA Cancers of the colon and rectum are the second leading cause of cancer death among adult Americans. When detected at early stages, colon ...

CHAPTER 11 ELECTIVE SURGERY FOR COLON CANCER 11.1 Operative technique The objective of surgical treatment of colon cancer is to remove the primary tumour and any regional spread that may have already occurred, without causing further dissemination of tumour, while at the same time preserving a reasonable quality of life for the patient. The prime question to be answered needs to be directed at the surgical pathology and technical aspects of management. The appropriate surgeon to undertake the surgery is addressed in Section 12.1. 11.2 High ligation The technique of colonic cancer resection has been debated widely throughout the 20 th and now the 21st century . Features emphasised include high ligation of the lymphovascular pedicle before manipulating the tumour, 1 wide excision, 2,3 and early isolation of the lymphovascular pedicle ...

The Northeast Regional Cancer Institute is a non-profit, community-based agency focusing on epidemiology research, education, and survivorship. The Cancer Institute invests all of its resources here in this region. Partnering with the Cancer Institute to achieve its goals are ten healthcare institutions: Allied Services/John Heinz Institute Community Medical Center Geisinger South Wilkes-Barre Marian Community Hospital Mercy Health Partners Moses Taylor Hospital/Mid-Valley Hospital Wayne Memorial Health System Wyoming Valley Health Care System Bittersweet S everal years ago my mother and I were having lunch when we started talking about the joys of life. My mother said she would feel her life was complete when my brother, Michael, was married and I had a baby. In October my brother was married and on that day I was five and a half months pregnant with my first ...

Developed by Pfizer in partnership with the Colon Cancer Alliance. CQ185572B © 2004 Pfizer Inc. All rights reserved. Printed in USA/September 2004 THE VOICE OF SURVIVORS Page 2 Treatment Journal Developed by Pfizer in partnership with the Colon Cancer Alliance. THE VOICE OF SURVIVORS Page 3 Page 4 Page 5 Treatment Journal Introduction . .3 Your Treatment Team .5 Appointments .11 Tracking Side Effects . .33 Personal Journal . .59 1 Page 6 This journal will help you keep track of your treatment and recovery. When you are dealing with cancer , it is very hard to remember questions you have for the doctor or even what the doctor says during a visit. Writing down your questions ahead of time, and what ...

Introduction Clinical and basic science research programs within the Michael E. DeBakey Department of Surgery continue to raise the standards each year. The success of the individual programs is recognizable through the increases in research funding, publications in quality journals and the international reputation of the department. In order to recognize the accomplishments of these principle investigators, plan our future missions and encourage young investigators, we are presenting the "2005 Molecular Surgeon Research Day," on December 16, 2005. During today’s event, all faculty, surgical residents/fellows, postdoctoral fellows, associates, students and other research staff in the department are invited and encouraged to attend. During the event, our visions, current status and future plans for our research programs will be discussed. Ten principal investigators will receive the "2005 Molecular Surgeon ...

Colon cancer prognosis prediction by gene expression profiling Alain Barrier* ,1,2,3 , Antoinette Lemoine 4 , Pierre-Yves Boelle 2 , Chantal Tse 5 , Didier Brault 5 , Franck Chiappini 4 , Julia Breittschneider 6 , Francois Lacaine 1 , Sidney Houry 1 , Michel Huguier 1 , Mark J Van der Laan 3 , Terry Speed 6 , Brigitte Debuire 4 , Antoine Flahault 2 and Sandrine Dudoit 3 1 Service de Chirurgie Digestive, Hôpital Tenon, Université Pierre et Marie Curie, Assistance Publique, 75020 Paris, France; 2 INSERM U444, Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie, 75571 Paris Cedex 12, France; 3 Division of Biostatistics, ...

50 Y EARS OR O LDER ? G ET T ESTED R EGULARLY FOR C OLON C ANCER . March 2005 Colon cancer is cancer of the colon or rectum. If you are 50 or older, you should begin having regular tests for colon cancer . There are different kinds of tests. Talk with your doctor about which type of test you should have. These tests can find polyps in your colon or rectum before they turn into cancer . When colon cancer is found early, medical treatment works best and can save your life. Testing Can Save YOUR Life In the early stages of colon cancer , there are often no symptoms . This means you could have colon cancer and ...

135 OCCUPATIONAL EXPOSURES AND THE RISK OF COLON CANCER Robert A. Pinter, University of Utah Kurt T. Hegmann, University of Utah Han S. Kim, University of Utah Chad M. Cox, University of Utah Martha L. Slattery, University of Utah rpinter@dfpm.utah.edu ABSTRACT Persons performing various occupations have been reported as at-risk for colorectal cancer by prior investigators. Occupational exposures have been inferred as risk factors based upon assumed levels of exposure, particularly to asbestos. This population-based incident case (n=1449) – control (n=1763) study of colon cancer utilized participants from Utah, Minnesota, and northern California. Occupational exposures to asbestos, benzene, electromagnetic fields, formaldehyde, lead, and solvents were assigned using a job exposure matrix. Potential confounders were evaluated including tobacco, nonsteroidal anti- inflammatory ...

Issue 26 Q4 2005 Table of Contents 1. Diabetics at higher risk of colon cancer 2. Many docs reluctant to prescribe insulin 3. Rimonabant can lower heart disease risk factors 4. Breastfeeding may reduce mothers' diabetes risk 5. Vitamin A compound heals diabetic foot ulcers 6. November Poll Results Which Meal is Hardest for You to Manage? 7. dLifeTV For Your Diabetes Life! 8. Help us improve our web content. Take the poll 9. Ask Dr. Ginsberg &sh...

Guideline Updated: 12 December 2005 Specialty: Gastroenterology • Colon Cancer Screening in Average Risk Patients Referral Guideline Diagnosis/Definition • All patients > 50 yrs that have NONE of the following risk factors: positive occult blood or frank bleeding, iron deficiency anemia, history of colonic adenomas, family history of colon cancer , ulcerative colitis, or history of colon cancer (see individual referral guidelines for each of those). Initial Diagnosis and Management • History. Occult blood annually ONLY if the patient does not wish colonos...

© The Ulster Medical Society, 2005. 14 The Ulster Medical Journal The Ulster Medical Journal, Volume 74 No. 1, pp. 14-21, May 2005. Review Hereditary Non-Polyposis colon cancer LA Devlin, JH Price, PJ Morrison Belfast City Hospital, Lisburn Road, Belfast BT9 7AB. Department of Medical Genetics: LA Devlin, MB, BCh, MRCPCH, Research Fellow. PJ Morrison, MD, FRCPCH, FFPHMI, Professor of Human Genetics. Department of Gynaecological Surgery: JH Price, MD, FRCOG, Consultant Gynaecologist. Correspondence to Professor Morrison. INTRODUCTION Colorectal cancer is the second most common cause of cancer related death and the third most common cancer in the United Kingdom. 1, 2 Around 80% of cases present with spread to the bowel wall. Early diagnosis and recognition of symptoms can now be achieved by screening asymptomatic ...

Joe Manchin III Keith Huffman Governor Acting Co-Director and General Counsel Toll-free: 1-888-680-7342 • Phone: 1-304-558-7850 • Fax: 1-304-558-2516 • Internet: www.wvpeia.com May 30, 2005 Dear PEIA Member: Have you had your colon cancer screening? The Public Employees Insurance Agency (PEIA) and Acordia National have joined forces in ensuring that PEIA members receive appropriate care for medical conditions. We want to make certain each member is aware of the opportunities that are available for improved health. Using guidelines from respected organizations like the American Cancer Society, we are offering a new healthcare initiative, called Healthy Tomorrows . As part of this Program, PEIA and Acordia National reviewed claims data for the past five years and found that you may be due for a colon cancer screening test. The chart below lists the colon cancer ...

Genetic Testing For Colon Cancer : Blood, Tissue, or Stool? Steven H. Itzkowitz, M.D. The Dr. Burrill B. Crohn Professor of Medicine Mount Sinai School of Medicine New York, presented at the annual course of the New York Society for Gastrointestinal Endoscopy in NY, December, 2004 NY 10029 Background All new cases of colorectal cancer (CRC) that are diagnosed each year in this country can be considered in three general categories: hereditary, familial, and sporadic (no apparent genetic predisposition). Even though the hereditary syndromes, combined, account for fewer than 5% of all CRC cases, the molecular pathogenesis underlying these syndromes has taught us a great deal about all CRCs, thereby opening the opportunity to develop genetic tests of colon cancer predisposition. It is believed that practically all CRCs arise from a preexisting adenomatous polyp. ...

Pancreas Cancer Treatment Comparison to NCCN Guidelines August 2004 By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Data Source: Cancer Registry data of AJCC summary stage I, II, III pancreas cancer diagnosed January 1, 2000 to December 31, 2003. NCCN guidelines for pancreas cancer . Reason for Report: To determine if St. Joseph Hospital is following the NCCN guidelines for pancreas cancer . Findings: There were 23 cases of stage I, II, III pancreas cancer diagnosed for the above time period. Number following all NCCN treatment recommendations = 17 (73.9%) Number not following all NCCN recommendations = 6 (26.1%) Not following tissue diagnosis recommendation = 3 (13%) Not following surgery recommendation = 0 Not following radiation recommendation = 4 (17.4%) Not following chemo recommendation = 4 (17.4%) Reasons ...

Colon Cancer Follow-Up Sheet To begin the chart, fill in the date of diagnosis. Add the years/months in the first column t o the date of diagnosis to obtain target dates. Record visits, t est dates, and CEA values in the rows corresponding to each target date as they are completed. Darkened rows indicate that a particular procedure is not req uired at that time. Programmable follow-up sheet available at www.asco.org/guidelines. Patient Name: Date of Birth: MR#: Date of Diagnosis (DOD): Estimated Target Dates Dates ...

Antiproliferative activity of PEP005, a novel agent that activates PKC d and inhibits PKCa, alone and in combination with cytotoxic agents in human solid tumor cancer cell lines Karim A. Benhadji 1 , Maria Serova 2 , Aïda Ghoul 1 , Esteban Cvitkovic 3 , Steven M. Ogbourne 4 , Peter Welburn 4 , Sandrine Faivre 5 , François Lokiec 1 , Fabien Calvo 2 , Eric Raymond 5 1 Department of clinical Pharmacology, Centre René Huguenin, Saint-Cloud, France; 2 INSERM U716 Saint-Louis Hospital, Paris; 3 CAC Oncology, Le Kremlin Bicetre, France; 4 Peplin Ltd., Newstead, Australia; 5 Department of Medical Oncology, Hopital Beaujon, Clichy, ...

EVIDENCE-BASED SERIES #2-20-2 Evidence-based Series #2-20-2 Laparoscopic Surgery for Cancer of the Colon A. Smith, R.B. Rumble, B. Langer, H. Stern, F. Schwartz, M. Brouwers, and members of Cancer Care Ontario’s Laparoscopic Colon Cancer Surgery Expert Panel and Program in Evidence-based Care Report Date: September 2005 Evidence-based Series #2-20-2 is comprised of 3 sections: Section 1: A Clinical Practice Guideline Section 2: A Systematic Review Section 3: Guideline Development and External Review: Methods and Results A Quality Initiative of Cancer Care Ontario’s Surgical Oncology Program and the Program in Evidence-based Care For further information about this series, please contact: Dr. Andy Smith Toronto-Sunnybrook Hospital 2075 Bayview Avenue Toronto, ON. M4N 3M5 Email: andy.smith@sw.ca TEL: 416-480-4027 ...

Colon Cancer : Caring for the Aging Key Survey Findings As part of the Colon Cancer : Caring for the Aging Program, the Alliance for Aging Research commissioned a survey of oncologists to explore the role of caregivers in patient care and decision-making. Over 100 oncologists were interviewed, all of whom practice in the United States, treat at least 10 colorectal cancer patients per month, and have been practicing between 3 and 30 years. The survey included questions on how many patients have caregivers, who those caregivers are, their importance in disease management, their primary roles, and their participation in communication and treatment options. Some of the key findings from the survey are outlined below: • Six out of 10 (62.9%) colon cancer patients are 65 years or older. • 64% of physicians strongly or somewhat agree that elderly colon cancer patients ...

1 Physician Barriers to Colon Cancer Screening Several studies have demonstrated that physician recommendation is a powerful predictor of colon cancer screening. 1-3 In Washington State, having discussed colon cancer screening with a physician significantly increased the odds of being up-to-date for colon cancer screening. 4 Despite the power of physician recommendations, colon cancer screening rates are low. Physicians and other healthcare providers face multiple barriers to colon cancer screening. In this report, we discuss recent literature concerning these barriers, including physician knowledge, practice characteristics, and patient factors. Physician Knowledge A recent survey of internal medicine residents, internal medicine attendings, and medical students revealed that knowledge of American Cancer Society (ACS) colon cancer screening ...

1 Patient Barriers to Colon Cancer Screening Colon cancer is the second leading cause of cancer deaths in the US 1 , but it is also one of the most preventable forms of cancer . 2 Screening has been shown to reduce deaths related to colon cancer , and also to reduce the incidence through the identification of premalignant polyps. 3 The populations most at risk are men and women with a family history of colon cancer and those above the age of 50. According to the Agency for Health Care Research and Quality, there are several different screening strategies that are widely accepted for use: a fecal occult blood test (FOBT) administered annually, the flexible sigmoidoscopy administered every 5 years, a combination of FOBT annually and sigmoidoscopy every 5 years, a colonoscopy administered every 10 years, or a double contrast barium enema administered ...

1 Colon Cancer Screening Interventions There is limited research on successful interventions to increase colon cancer screening. The Task Force on Community Preventive Services conducted a comprehensive literature review of studies published from 1966 until April, 2001. They used criteria based on execution, design suitability, number of studies, consistency of findings, and effect size to determine successful interventions. Based on these criteria, the Task Force found strong evidence to recommend reducing structural barriers, and sufficient evidence to recommend the use of client reminders to increase colon cancer screening. There was insufficient evidence to recommend any of the other intervention methodologies studied, including one-on-one education, group education, reducing client costs, small media, client incentives combined with reminders, and multi-component interventions that include ...

1 Fecal Occult Blood Tests The fecal occult blood test (FOBT) is the least expensive and easiest colon cancer screening test recommended by national guidelines. 1-5 Large randomized clinical trials have also shown that FOBT reduces mortality from colon cancer . 6 However, the effectiveness of FOBTs is partially determined by how providers conduct the tests. Providers must select the brand of FOBT to use, including whether to use a guaiac-based test or an immunochemical test. Providers should conduct the FOBT through an at-home multiple specimen test rather than a single sample in-clinic test. In addition, when a patient has a positive FOBT, providers must order the appropriate follow-up test. While FOBTs are shown to reduce colorectal cancer incidence and mortality, the effectiveness of FOBTs depend on the choices providers make. 7-12 FOBT Types ...

F R E Q U E N T LY A S K E D Q U E S T I O N S WomensHealth.gov 1-800-994-9662 TDD: 1-888-220-5446 Q: Why should I be concerned about cancer of the colon and the rectum? Cancer of the A: Colorectal cancer affects an equal Colon and the number of women and men each year, and is most often found in people over the age of 50. Excluding skin cancer , it Rectum is the third most diagnosed cancer for women, following breast and lung cancers. And it is the second leading cause of cancer death in the United Q: What is cancer of the colon and States. Colorectal cancer is often called the rectum? a “silent” disease since symptoms don’t A: Cancer is a disease in which certain always develop ...

Facts About Colon Cancer Colorectal cancer is a disease in which malignant ( cancer ) cells form in the tissues of the large intestine and rectum. Colorectal cancer af- fects approximately 6 percent of the total population in the United States. It is the third most common type of cancer and the second leading cause of cancer -related death. Screening and detection are the keys to prevent death from colon cancer . Colorectal cancer can be cured if detected in the early stages, and it can actually be prevented through early detection and removal of pre- cancerous and cancerous growths called polyps. There are many different ways to screen and diagnose colorectal cancer . Some of the conventional methods include: · Flexible Sigmoidoscopy · Barium Enema · Colonoscopy Virtual Colonoscopy ...

What You Need To Know About Cancer of the Colon and Rectum U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute ™ What You Need To Know About Index Page 2 This booklet is about colon and rectal cancer . The Cancer Information Service can help you learn more about this disease. The staff can talk with you in English or Spanish. The number is 1–800–4– CANCER (1–800–422–6237). The number for deaf and hard of hearing callers with TTY equipment is 1–800–332–8615. The call is free. Este folleto es acerca del cáncer de colon y recto. Llame al Servicio de Información sobre el Cáncer para saber más sobre esta enfermedad. Este servicio tiene personal que habla español. ...

Yuriko Mori, MD, PhD University of Maryland School of Medicine Baltimore, MD A global search of hypermethylated genes in colon cancer In the United States, colon cancer is the most prevalent cancer and the leading cause of death among digestive system diseases. In order to advance clinical care and earlier detection of this deadly disease, a comprehensive understanding of the cascade of genetic abnormalities occurring during the progress of the disease is indispensable. The reasons are: 1. It will result in developments of new therapies to identifying genes whose abnormality is vital to maintenance or progression of cancer , and 2. It will be of great diagnostic value to identify genes whose abnormalities are signs for either undetected cancer , positive or negative prognosis, or positive or negative response to a certain treatment. Abnormal increase of methylation (hypermethylation) ...

FDA approves Xeloda for adjuvant Dukes' C colon cancer From: Richard Pazdur, MD Director, Division of Oncology Drug Products, Center for Drug Evaluation and Research, FDA On June 15, 2005, the U.S. Food and Drug Administration approved capecitabine (Xeloda (r) Tablets, Hoffman-LaRoche Inc.) as a single-agent adjuvant treatment for Dukes' stage C colon cancer patients who have undergone complete resection of the primary tumor in those instances when fluoropyrimidine therapy alone would be preferred. Approval is based on non-inferiority in disease-free survival (DFS) to bolus 5-fluorouracil plus leucovorin (5-FU/LV). In 2004, the FDA approved oxaliplatin for injection (Eloxatin(tm)) in combination with infusional 5-FU/LV for adjuvant stage III colon cancer . Although neither capecitabine nor the combination of oxaliplatin plus 5-FU/LV prolonged overall survival in the adjuvant setting, ...

"As for what we gained from attending the conference, there are so many things As for what we gained from attending the conference, there are so many things that it's difficult to mention them all. However, we feel that the entire weekend that it's difficult to mention them all. However, we feel that the entire weekend can be summed up in one word: can be summed up in one word: hope hope . Upon learning what my wife was facing, . Upon learning what my wife was facing, hope is the one thing that we've found it very difficult to maintain throughout the hope is the one thing that we've found it very difficult to maintain throughout the whole process of chemo and radiation. With the help of the Richard Farrell whole process of chemo and radiation. With the help of the Richard Farrell Memorial Scholarship Fund we were able to attend the conference which helped Memorial Scholarship Fund we were able to attend ...